Jeffrey Kraws

Jeffrey Kraws

Chairman bei AVIVAGEN INC.

Vermögen: 328 224 $ am 31.12.2023

59 Jahre
Finance
Health Technology
Retail Trade

Profil

Jeffrey J.
Kraws
is the founder of Crystal Research Associates (founded in 2003) where he holds the title of Chief Executive Officer.
He is also the founder of TopHat Capital LLC (founded in 2012) where he holds the title of Partner.
Additionally, he is the founder of Cra Advisors LLC (founded in 2003) where he holds the title of Chief Executive Officer.
Mr. Kraws's current job(s) include being the Independent Chairman at Avivagen, Inc. (since 2013), the Independent Non-Executive Chairman at Theriva Biologics, Inc. (since 2006), a Partner at Phoenix Holdings Ltd.
(US) (since 2015), a Partner at Grannus Securities Pty Ltd.
(since 2015), and a Partner at US Medical Innovations LLC.
Mr. Kraws's former job(s) include being a Managing Director-Healthcare Research at Ryan, Beck & Co., Inc., a Director at Saleen Automotive, Inc. (from 2013 to 2020), a Managing Director & Research Director at Gruntal & Co. LLC, a Director at Innovation1 Biotech, Inc. (from 2021 to 2023), a Senior Analyst at The Buckingham Research Group, Inc., an MD-Healthcare Research Group at First Union Securities, the President of IRG Research Group, the Co-President of The Investor Relations Group, Inc., the President of Ra Medical Systems, Inc. (from 2016 to 2021), and the President-Brokerage & Investment Banking Operation at Abb Aros Securities, Inc.Mr. Kraws's education history includes an MBA degree from Cornell University (conferred in 1988) and an undergraduate degree from State University of New York at Buffalo (conferred in 1986).

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
12.01.2024 1 389 055 ( 6,79% ) 327 817 $ 31.12.2023
25.03.2024 654 ( 0,00% ) 307 $ 31.03.2024
03.03.2023 50 000 ( 0,06% ) 100 $ 31.03.2024

Aktive Positionen von Jeffrey Kraws

UnternehmenPositionBeginn
THERIVA BIOLOGICS, INC. Chairman 14.05.2012
AVIVAGEN INC. Chairman 14.05.2019
Founder 01.01.2003
Grannus Securities Pty Ltd. Corporate Officer/Principal 01.11.2015
Chief Executive Officer 01.01.2003
Corporate Officer/Principal 01.11.2015
Founder 01.02.2012
Corporate Officer/Principal -
Alle aktiven Positionen von Jeffrey Kraws

Ehemalige bekannte Positionen von Jeffrey Kraws

UnternehmenPositionEnde
INNOVATION1 BIOTECH INC. Chief Executive Officer 06.12.2022
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ -
Sehen Sie sich die Erfahrung von Jeffrey Kraws im Detail an

Ausbildung von Jeffrey Kraws

Cornell University Masters Business Admin
State University of New York at Buffalo Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jeffrey Kraws im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

20

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
AVIVAGEN INC.

Health Technology

THERIVA BIOLOGICS, INC.

Health Technology

INNOVATION1 BIOTECH INC.

Retail Trade

Private Unternehmen15

Finance

Retail Trade

Finance

First Union Securities

Finance

IRG Research Group

Finance

Gruntal & Co. LLC

Government

Finance

Commercial Services

Health Technology

Finance

Grannus Securities Pty Ltd.

Finance

Abb Aros Securities, Inc.

Health Technology

Finance

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Jeffrey Kraws